医薬品無菌性試験の世界市場レポート 2025年

医薬品無菌性試験の市場規模は今後数年で急成長が見込まれます。2029年には年間平均成長率（CAGR）20.0％で31億8,000万米ドルに成長します。予測期間の成長は、バイオ医薬品の成長、個別化医療、アウトソーシングの増加傾向、品質保証の重視、パンデミック対策などに起因すると考えられます。予測期間の主な動向には、迅速な微生物学的手法、配合製品、データの完全性とデジタル化、自動化とロボット、高度な分析技術などがあります。

医薬品無菌性試験市場の発展は、医薬品上市の急増と研究開発（R&D）投資の増加に起因します。医薬品製造における無菌性の維持は、汚染を防止し、医薬品中に生存可能な微生物が存在しないことを保証するために極めて重要です。特に2022年3月、英国政府は革新的な治療法やツールの研究開発イニシアチブに3億4,700万米ドル（2億6,000万英ポンド）を拠出することを約束し、医薬品業界の発展に尽力する姿勢を示しました。さらに、2021年12月に発表されたIQVIAのレポートでは、今後5年間で新薬の上市が大幅に増加し、特に専門薬、ニッチ薬、希少薬において、新製品への支出が大幅に増加すると予測しています。

生物製剤の売上増加は、医薬品無菌性試験市場の成長を大きく促進すると予測されます。生物由来の医薬品である生物製剤には、ワクチン、血液および血液成分、アレルゲン、体細胞、遺伝子治療薬、組織、組換え治療用タンパク質など幅広い製品が含まれます。これらの生物製剤の無菌性を確保することは極めて重要であり、医薬品無菌性試験は、これらの製品が患者投与前に微生物汚染を受けていないことを確認するために不可欠な品質管理を提供します。例えば、2023年11月、カナダの規制機関である特許薬価レビュー委員会は、がん治療薬の売上が2021年に10％増加し、2022年にはさらに12％増加したと報告しました。このような生物製剤の販売動向は、こうした救命治療の安全性と有効性を維持するための無菌検査サービスに対する需要の高まりを裏付けています。その結果、生物製剤販売の急増は医薬品無菌性試験市場の主な促進要因であり、バイオ医薬品業界における厳格な試験プロトコルの重要な役割を浮き彫りにしています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の医薬品無菌性試験市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の医薬品無菌性試験市場：成長率分析
• 世界の医薬品無菌性試験市場の実績：規模と成長、2019～2024年
• 世界の医薬品無菌性試験市場の予測：規模と成長、2024～2029年、2034年
• 世界の医薬品無菌性試験総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の医薬品無菌性試験市場：サンプル別、実績と予測、2019～2024年、2024～2029年、2034年
• 無菌薬剤
• 医療機器
• 生物製剤および治療薬
• 世界の医薬品無菌性試験市場：製品タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 機器
• キットと試薬
• サービス
• 世界の医薬品無菌性試験市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 社内
• アウトソーシング
• 世界の医薬品無菌性試験市場：試験タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 無菌試験
• バイオバーデン試験
• 細菌エンドトキシン検査
• 世界の医薬品無菌性試験市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 調剤薬局
• 医療機器企業
• 製薬会社
• 世界の医薬品無菌性試験市場：無菌薬剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 注射薬
• 輸液ソリューション
• 点眼薬
• 世界の医薬品無菌性試験市場：医療機器のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 手術器具
• インプラント
• カテーテル
• 世界の医薬品無菌性試験市場：生物製剤および治療薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ワクチン
• 遺伝子治療
• 細胞療法

第7章 地域別・国別分析

• 世界の医薬品無菌性試験市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の医薬品無菌性試験市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品無菌性試験市場：競合情勢
• 医薬品無菌性試験市場：企業プロファイル
  • Pacific Biolabs Inc. Overview, Products and Services, Strategy and Financial Analysis
  • STERIS Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Boston Analytical Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Gibraltar Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sartorius AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Solvias AG
• SGS S.A.
• Toxikon Inc.
• Pace Analytical Services LLC
• Charles River Laboratories International Inc.
• Nelson Laboratories Inc.
• Rapid Micro Biosystems Inc.
• bioMerieux Inc.
• Merck KGaA
• WuXi AppTec
• Sotera Health LLC
• Dynalabs LLC
• Infinity Laboratories
• Eurofins Scientific SE
• Avomeen Analytical Services

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 医薬品無菌性試験市場2029：新たな機会を提供する国
• 医薬品無菌性試験市場2029：新たな機会を提供するセグメント
• 医薬品無菌性試験市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pharmaceutical sterility testing is a critical process designed to determine whether biological parenteral products intended for human use contain any extraneous, viable microorganisms. Ensuring the absence of contaminants is crucial for patient safety and the overall quality of medical products. Sterility testing guarantees that the products offered are appropriately free from harmful microorganisms.

Within pharmaceutical sterility testing, two primary types exist: in-house testing and outsourced testing. Various tests, including sterility testing, bioburden testing, and bacterial endotoxin testing, are conducted on sterile drugs, medical devices, biologics, and therapeutics. The bacterial endotoxin test, an in vitro assay, detects bacterial endotoxins by lysing blood cells from horseshoe crabs. Products utilized in this process include instruments, kits, reagents, and services.

The pharmaceutical sterility testing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical sterility testing market statistics, including pharmaceutical sterility testing industry global market size, regional shares, competitors with a pharmaceutical sterility testing market share, detailed pharmaceutical sterility testing market segments, pharmaceutical sterility testing market trends and opportunities, and any further data you may need to thrive in the pharmaceutical sterility testing industry. This pharmaceutical sterility testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical sterility testing market size has grown strongly in recent years. It will grow from $1.41 billion in 2024 to $1.54 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to rising demand for quality pharmaceutical products, growing emphasis on drug safety and efficacy, growing demand for biologics and biosimilar drugs, increasing prevalence of infectious diseases, and rising investments in life science research.

The pharmaceutical sterility testing market size is expected to see rapid growth in the next few years. It will grow to $3.18 billion in 2029 at a compound annual growth rate (CAGR) of 20.0%. The growth in the forecast period can be attributed to biopharmaceutical growth, personalized medicine, growing trend of outsourcing, quality assurance emphasis, pandemic preparedness. Major trends in the forecast period include rapid microbiological methods, combination products, data integrity and digitalization, automation and robotics, advanced analytical techniques.

Growth in the pharmaceutical sterility testing market is attributed to an upsurge in drug launches and increased investment in research and development (R&D). Maintaining sterility in drug manufacturing is crucial to prevent contamination and ensure the absence of viable microorganisms in medications. Notably, in March 2022, the UK government pledged a substantial $347 million (£260 million) towards R&D initiatives for innovative treatments and tools, signifying a commitment to advancing the pharmaceutical landscape. Additionally, IQVIA's report from December 2021 projects a significant rise in new drug introductions over the next five years, particularly in specialty, niche, and orphan drugs, accompanied by a substantial increase in spending on new products.

The rise in biologics sales is anticipated to significantly propel the growth of the pharmaceutical sterility testing market. Biologics, which are medicines derived from living organisms, encompass a wide range of products, including vaccines, blood and blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Ensuring the sterility of these biologics is critical, as pharmaceutical sterility testing provides essential quality control to verify that these products are free from microbial contamination prior to patient administration. For example, in November 2023, the Patented Medicine Prices Review Board, a Canada-based regulatory agency, reported that sales of oncology medicines increased by 10% in 2021 and saw a more significant rise of 12% in 2022. This growing trend in biologics sales underscores the heightened demand for sterility testing services to maintain the safety and efficacy of these life-saving treatments. Consequently, the surge in biologics sales is a key driver for the pharmaceutical sterility testing market, highlighting the critical role of rigorous testing protocols in the biopharmaceutical industry.

Key players in the pharmaceutical sterility testing market are introducing technologically advanced solutions, such as the sterility test isolator workstation (STIW), to address testing challenges and minimize erroneous results. The STIW, a specialized containment system, creates a sterile environment for conducting sterility tests on pharmaceutical products. For example, AUSTAR Group unveiled the Sterility Test Isolator Workstation (STIW) in March 2022 as part of their 'Standards' product range, featuring UDAF and TURB models. This barrier isolator technology significantly reduces false positives, fostering confidence in lab results while lowering operational costs. Designed for secure sterility testing, the STIW ensures protection against contamination, adhering to stringent guidelines. Its integrated bio-decontamination system expedites processing within 30 minutes, optimizing workflow efficiency for operators.

Major companies operating in the pharmaceutical sterility testing market include Pacific Biolabs Inc., STERIS Corporation, Boston Analytical Inc., Gibraltar Laboratories Inc., Sartorius AG, Solvias AG, SGS S.A., Toxikon Inc., Pace Analytical Services LLC, Charles River Laboratories International Inc., Nelson Laboratories Inc., Rapid Micro Biosystems Inc., bioMerieux Inc., Merck KGaA, WuXi AppTec, Sotera Health LLC, Dynalabs LLC, Infinity Laboratories, Eurofins Scientific SE, Avomeen Analytical Services, Microbac Laboratories Inc., Analytical Lab Group LLC, North American Science Associates Inc., Medical Device Testing Services Inc., Microtest Laboratories Inc., BioScreen Testing Services Inc., Microchem Laboratory Inc., Bactolac Pharmaceutical Inc., Micro Quality Labs Inc., Boston Microfluidics Inc., BioPharma Services Inc., Microbiology Research Associates, BioScience Laboratories Inc.

North America was the largest region in the pharmaceutical sterility testing market in 2024. The Middle East is expected to be the fastest-growing region in the global pharmaceutical sterility testing market share during the forecast period. The regions covered in the pharmaceutical sterility testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the pharmaceutical sterility testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The pharmaceutical sterility testing market includes revenues earned by entities by membrane filtration, direct transfer (product immersion), and product flush. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Sterility Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical sterility testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical sterility testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical sterility testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Sample: Sterile Drugs; Medical Devices; Biologics and Therapeutics
• 2) By Product Type: Instruments; Kits and Reagents; Services
• 3) By Type: In- house; Outsourcing
• 4) By Test Type: Sterility Testing; Bioburden Testing; Bacterial Endotoxin Testing
• 5) By End- User: Compounding Pharmacies; Medical Devices Companies; Pharmaceutical Companies
• Subsegments:
• 1) By Sterile Drugs: Injectable Drugs; Infusion Solutions; Ophthalmic Solutions
• 2) By Medical Devices: Surgical Instruments; Implants; Catheters
• 3) By Biologics And Therapeutics: Vaccines; Gene Therapies; Cell Therapies
• Companies Mentioned: Pacific Biolabs Inc.; STERIS Corporation; Boston Analytical Inc.; Gibraltar Laboratories Inc.; Sartorius AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Sterility Testing Market Characteristics

3. Pharmaceutical Sterility Testing Market Trends And Strategies

4. Pharmaceutical Sterility Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pharmaceutical Sterility Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceutical Sterility Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceutical Sterility Testing Market Growth Rate Analysis
• 5.4. Global Pharmaceutical Sterility Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceutical Sterility Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceutical Sterility Testing Total Addressable Market (TAM)

6. Pharmaceutical Sterility Testing Market Segmentation

• 6.1. Global Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sterile Drugs
• Medical Devices
• Biologics and Therapeutics
• 6.2. Global Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Kits and Reagents
• Services
• 6.3. Global Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In-house
• Outsourcing
• 6.4. Global Pharmaceutical Sterility Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sterility Testing
• Bioburden Testing
• Bacterial Endotoxin Testing
• 6.5. Global Pharmaceutical Sterility Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Compounding Pharmacies
• Medical Devices Companies
• Pharmaceutical Companies
• 6.6. Global Pharmaceutical Sterility Testing Market, Sub-Segmentation Of Sterile Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Drugs
• Infusion Solutions
• Ophthalmic Solutions
• 6.7. Global Pharmaceutical Sterility Testing Market, Sub-Segmentation Of Medical Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Instruments
• Implants
• Catheters
• 6.8. Global Pharmaceutical Sterility Testing Market, Sub-Segmentation Of Biologics And Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines
• Gene Therapies
• Cell Therapies

7. Pharmaceutical Sterility Testing Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Sterility Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceutical Sterility Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Sterility Testing Market

• 8.1. Asia-Pacific Pharmaceutical Sterility Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Sterility Testing Market

• 9.1. China Pharmaceutical Sterility Testing Market Overview
• 9.2. China Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Sterility Testing Market

• 10.1. India Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Sterility Testing Market

• 11.1. Japan Pharmaceutical Sterility Testing Market Overview
• 11.2. Japan Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Sterility Testing Market

• 12.1. Australia Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Sterility Testing Market

• 13.1. Indonesia Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Sterility Testing Market

• 14.1. South Korea Pharmaceutical Sterility Testing Market Overview
• 14.2. South Korea Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Sterility Testing Market

• 15.1. Western Europe Pharmaceutical Sterility Testing Market Overview
• 15.2. Western Europe Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Sterility Testing Market

• 16.1. UK Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Sterility Testing Market

• 17.1. Germany Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Sterility Testing Market

• 18.1. France Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Sterility Testing Market

• 19.1. Italy Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Sterility Testing Market

• 20.1. Spain Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Sterility Testing Market

• 21.1. Eastern Europe Pharmaceutical Sterility Testing Market Overview
• 21.2. Eastern Europe Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Sterility Testing Market

• 22.1. Russia Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Sterility Testing Market

• 23.1. North America Pharmaceutical Sterility Testing Market Overview
• 23.2. North America Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Sterility Testing Market

• 24.1. USA Pharmaceutical Sterility Testing Market Overview
• 24.2. USA Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Sterility Testing Market

• 25.1. Canada Pharmaceutical Sterility Testing Market Overview
• 25.2. Canada Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Sterility Testing Market

• 26.1. South America Pharmaceutical Sterility Testing Market Overview
• 26.2. South America Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Sterility Testing Market

• 27.1. Brazil Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Sterility Testing Market

• 28.1. Middle East Pharmaceutical Sterility Testing Market Overview
• 28.2. Middle East Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Sterility Testing Market

• 29.1. Africa Pharmaceutical Sterility Testing Market Overview
• 29.2. Africa Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Sterility Testing Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Sterility Testing Market Competitive Landscape
• 30.2. Pharmaceutical Sterility Testing Market Company Profiles
  • 30.2.1. Pacific Biolabs Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. STERIS Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Boston Analytical Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Gibraltar Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Sterility Testing Market Other Major And Innovative Companies

• 31.1. Solvias AG
• 31.2. SGS S.A.
• 31.3. Toxikon Inc.
• 31.4. Pace Analytical Services LLC
• 31.5. Charles River Laboratories International Inc.
• 31.6. Nelson Laboratories Inc.
• 31.7. Rapid Micro Biosystems Inc.
• 31.8. bioMerieux Inc.
• 31.9. Merck KGaA
• 31.10. WuXi AppTec
• 31.11. Sotera Health LLC
• 31.12. Dynalabs LLC
• 31.13. Infinity Laboratories
• 31.14. Eurofins Scientific SE
• 31.15. Avomeen Analytical Services

32. Global Pharmaceutical Sterility Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Sterility Testing Market

34. Recent Developments In The Pharmaceutical Sterility Testing Market

35. Pharmaceutical Sterility Testing Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceutical Sterility Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Sterility Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Sterility Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer